Literature DB >> 6279057

Immunogenicity of a subviral herpes simplex type 1 preparation: reduction of recurrent disease in mice.

V Slichtová, L Kutinová, V Vonka.   

Abstract

Immunization of mice with a relatively small dose of subviral herpes simplex type 1 vaccine used prior to homotypic virus infection reduced the frequency of recurrent disease. However, the same vaccine dose administered after virus infection did not result in significant reduction of recurrences.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6279057     DOI： 10.1007/bf01315176

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  6 in total

1.  Production and some properties of neutralizing antigens of herpes simplex virus.

Authors:  L Kutinová; V Vonka; D Rezácová
Journal:  Acta Virol       Date:  1977-05       Impact factor: 1.162

2.  Trauma to the skin causes recurrence of herpes simplex in the mouse.

Authors:  T J Hill; W A Blyth; D A Harbour
Journal:  J Gen Virol       Date:  1978-04       Impact factor: 3.891

3.  Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.

Authors:  L Kutinová; V Vonka; V Slichtová
Journal:  Acta Virol       Date:  1980-12       Impact factor: 1.162

4.  Immunogenicity of subviral herpes simplex virus type 1 preparation: protection of mice against intradermal challenge with type 1 and type 2 viruses.

Authors:  V Slichtová; L Kutinová; V Vonka
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

5.  Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.

Authors:  J Rajcáni; L Kutinová; V Vonka
Journal:  Acta Virol       Date:  1980-05       Impact factor: 1.162

6.  Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.

Authors:  L Kutinová; V Vonka
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441
  6 in total
  2 in total

1.  Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c mice.

Authors:  T A Thomson; J Hilfenhaus; H Moser; P S Morahan
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

Review 2.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.